{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:09:07Z","timestamp":1792008547356,"version":"4.4.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG3 DA050325"],"award-info":[{"award-number":["UG3 DA050325"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.brainresbull.2022.08.023","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T20:35:11Z","timestamp":1661632511000},"page":"155-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, reduces cue- and drug-induced fentanyl seeking in rats"],"prefix":"10.1016","volume":"189","author":[{"given":"Luke A.","family":"Urbanik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil K.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Grigson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2022.08.023_bib1","unstructured":"Administration, S.A.M.H.S.A., 2018. Key Substance Use and Mentalhealth Indicators in the United States: Results from the National Survey on Drug Use and Health, 2017."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.023_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.brainresbull.2022.08.023_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108614","article-title":"Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder","volume":"221","author":"Angarita","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","article-title":"Substance related and addictive disorders","author":"APA, DSM-5 Task Force","year":"2013"},{"key":"10.1016\/j.brainresbull.2022.08.023_bib5","series-title":"The Spike in Drug Overdose Deaths During the COVID-19 Pandemic and Policy Options to Move Forward. To the Point: Commonwealth Fund","author":"Baumgartner","year":"2021"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.08.023_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pbb.2010.04.016","article-title":"Dopamine and binge eating behaviors","volume":"97","author":"Bello","year":"2010","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.102121","article-title":"Sublingual buprenorphine-naloxone precipitated withdrawal-A case report with review of literature and clinical considerations","volume":"53","author":"Bhatia","year":"2020","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1523\/ENEURO.0443-18.2019","article-title":"Glucagon-like peptide-1 receptor agonist treatment does not reduce abuse-related effects of opioid drugs","volume":"6","author":"Bornebusch","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.brainresbull.2022.08.023_bib9","series-title":"Use of a GLP-1R Agonist to Treat Opioid Use Disorder","author":"Bunce","year":"2021"},{"key":"10.1016\/j.brainresbull.2022.08.023_bib10","unstructured":"Centers for Disease Control and Prevention, N.C.f.H.S., 2022. U.S. Overdose Deaths in 2021 Increased Half as Much as in 2020--but Are Still up 15%. [7\/6\/2022]; Available from: \u3008https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2022\/202205.htm\u3009."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainresbull.2017.09.002","article-title":"Once is too much: early development of the opponent process in taste reactivity behavior is associated with later escalation of cocaine self-administration in rats","volume":"138","author":"Colechio","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.023_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1037\/a0036264","article-title":"Once is too much: conditioned aversion develops immediately and predicts future cocaine self-administration behavior in rats","volume":"128","author":"Colechio","year":"2014","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","article-title":"Fentanyl: receptor pharmacology, abuse potential, and implications for treatment","volume":"106","author":"Comer","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"14","key":"10.1016\/j.brainresbull.2022.08.023_bib14","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.023_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/FBP.0000000000000609","article-title":"Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats","volume":"32","author":"Douton","year":"2021","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.023_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13117","article-title":"Glucagon-like peptide-1 receptor agonist, liraglutide, reduces heroin self-administration and drug-induced reinstatement of heroin-seeking behaviour in rats","volume":"27","author":"Douton","year":"2022","journal-title":"Addict. Biol."},{"issue":"5","key":"10.1016\/j.brainresbull.2022.08.023_bib17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/FBP.0000000000000685","article-title":"Acute glucagon-like peptide-1 receptor agonist liraglutide prevents cue-, stress-, and drug-induced heroin-seeking in rats","volume":"33","author":"Douton","year":"2022","journal-title":"Behav. Pharmacol."},{"issue":"5\u20136","key":"10.1016\/j.brainresbull.2022.08.023_bib18","article-title":"Escalation of drug self-administration as a hallmark of persistent addiction liability","volume":"24","author":"Edwards","year":"2013","journal-title":"Behav. Pharmacol."},{"issue":"7","key":"10.1016\/j.brainresbull.2022.08.023_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069010","article-title":"The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2022.08.023_bib20","doi-asserted-by":"crossref","unstructured":"Evans, B., Stoltzfus, B., Acharya, N., Nyland, J.E., Arnold, A.C., Freet, C.S., Bunce, S.C., & Grigson, P.S. (2022). Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats. Brain Research Bulletin.","DOI":"10.1016\/j.brainresbull.2022.08.022"},{"key":"10.1016\/j.brainresbull.2022.08.023_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","article-title":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic","volume":"46","author":"Fairbairn","year":"2017","journal-title":"Int J. Drug Policy"},{"issue":"Suppl. 4","key":"10.1016\/j.brainresbull.2022.08.023_bib22","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1086\/508180","article-title":"Opioid dependence: rationale for and efficacy of existing and new treatments","volume":"43","author":"Fiellin","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib23","series-title":"Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?\u00a0(EXALT)","author":"Fink-Jensen","year":"2021"},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.023_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ddmod.2009.03.005","article-title":"Reward comparison: the Achilles' heel and hope for addiction","volume":"5","author":"Grigson","year":"2008","journal-title":"Drug Discov. Today Dis. Models"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.023_bib25","doi-asserted-by":"crossref","DOI":"10.1037\/0735-7044.116.2.321","article-title":"Cocaine-induced suppression of saccharin intake: a model of drug-induced devaluation of natural rewards","volume":"116","author":"Grigson","year":"2002","journal-title":"Behav. Neurosci."},{"issue":"6","key":"10.1016\/j.brainresbull.2022.08.023_bib26","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1037\/0735-7044.121.6.1234","article-title":"Once is too much: conditioned changes in accumbens dopamine following a single saccharin-morphine pairing","volume":"121","author":"Grigson","year":"2007","journal-title":"Behav. Neurosci."},{"issue":"10","key":"10.1016\/j.brainresbull.2022.08.023_bib27","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/s41386-018-0010-3","article-title":"Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats","volume":"43","author":"Hernandez","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.023_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.14860","article-title":"Fentanyl depression of respiration: comparison with heroin and morphine","volume":"177","author":"Hill","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainresbull.2015.12.005","article-title":"Assessment of individual differences in the rat nucleus accumbens transcriptome following taste-heroin extended access","volume":"123","author":"Imperio","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.023_bib30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1037\/bne0000069","article-title":"Greater avoidance of a heroin-paired taste cue is associated with greater escalation of heroin self-administration in rats","volume":"129","author":"Imperio","year":"2015","journal-title":"Behav. Neurosci."},{"issue":"Suppl. 2","key":"10.1016\/j.brainresbull.2022.08.023_bib31","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0376-8716(03)00060-7","article-title":"Buprenorphine: how to use it right","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"4879","key":"10.1016\/j.brainresbull.2022.08.023_bib32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1126\/science.2903550","article-title":"Cellular and molecular mechanisms of drug dependence","volume":"242","author":"Koob","year":"1988","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.brainresbull.2022.08.023_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/add.12208","article-title":"Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness","volume":"108","author":"Krupitsky","year":"2013","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.brainresbull.2022.08.023_bib34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/npp.2013.17","article-title":"Extended heroin access increases heroin choices over a potent nondrug alternative","volume":"38","author":"Lenoir","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2022.08.023_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainresbull.2015.11.009","article-title":"Reward devaluation and heroin escalation is associated with differential expression of CRF signaling genes","volume":"123","author":"McFalls","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"10","key":"10.1016\/j.brainresbull.2022.08.023_bib36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/jne.12086","article-title":"Glucagon-like peptide-1 receptor agonist administration suppresses both water and saline intake in rats","volume":"25","author":"McKay","year":"2013","journal-title":"J. Neuroendocr."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.023_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib38","unstructured":"NIDA, 2019. Fentanyl Drug Facts."},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.023_bib39","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/dar.13228","article-title":"Managing opioid withdrawal precipitated by buprenorphine with buprenorphine","volume":"40","author":"Oakley","year":"2021","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib40","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212283","article-title":"A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond","volume":"4","author":"Prasad-Reddy","year":"2015","journal-title":"Drugs Context"},{"key":"10.1016\/j.brainresbull.2022.08.023_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.86","article-title":"Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels","volume":"6","author":"Reddy","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.brainresbull.2022.08.023_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2007.04.006","article-title":"Sublingual buprenorphine\/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone","volume":"90","author":"Rosado","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib43","unstructured":"S.A.M.H.S.A., 2021. National Survey on Drug Use and Health Annual National Report."},{"issue":"7","key":"10.1016\/j.brainresbull.2022.08.023_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2015.362","article-title":"Glucagon-like peptide-1 receptor activation in the ventral tegmental area decreases the reinforcing efficacy of cocaine","volume":"41","author":"Schmidt","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2022.08.023_bib45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2018.04.026","article-title":"Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016","volume":"189","author":"Socias","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.physbeh.2015.06.013","article-title":"The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice","volume":"149","author":"Sorensen","year":"2015","journal-title":"Physiol. Behav."},{"issue":"6","key":"10.1016\/j.brainresbull.2022.08.023_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12845","article-title":"Ghrelin receptor antagonism of fentanyl-induced conditioned place preference, intravenous self-administration, and dopamine release in the nucleus accumbens in rats","volume":"25","author":"Sustkova-Fiserova","year":"2020","journal-title":"Addict. Biol."},{"issue":"1\u20136","key":"10.1016\/j.brainresbull.2022.08.023_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0361-9230(82)90145-9","article-title":"The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat","volume":"9","author":"Swanson","year":"1982","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.023_bib49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.119.258566","article-title":"Noradrenergic mechanisms in fentanyl-mediated rapid death explain failure of naloxone in the opioid crisis","volume":"371","author":"Torralva","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2022.08.023_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.841873","article-title":"Sex- and dose-dependent differences in the development of an addiction-like phenotype following extended-access fentanyl self-administration","volume":"13","author":"Towers","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6560","key":"10.1016\/j.brainresbull.2022.08.023_bib51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/379069a0","article-title":"A role for glucagon-like peptide-1 in the central regulation of feeding","volume":"379","author":"Turton","year":"1996","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.brainresbull.2022.08.023_bib52","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1037\/a0016498","article-title":"Yoked delivery of cocaine is aversive and protects against the motivation for drug in rats","volume":"123","author":"Twining","year":"2009","journal-title":"Behav. Neurosci."},{"issue":"50","key":"10.1016\/j.brainresbull.2022.08.023_bib53","doi-asserted-by":"crossref","first-page":"10657","DOI":"10.1523\/JNEUROSCI.2080-18.2018","article-title":"Enhanced CRFR1-dependent regulation of a ventral tegmental area to prelimbic cortex projection establishes susceptibility to stress-induced cocaine seeking","volume":"38","author":"Vranjkovic","year":"2018","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.023_bib54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/npp.2014.188","article-title":"Compulsive-like responding for opioid analgesics in rats with extended access","volume":"40","author":"Wade","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.08.023_bib55","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"11","key":"10.1016\/j.brainresbull.2022.08.023_bib56","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.biopsych.2011.02.014","article-title":"Cocaine cues drive opposing context-dependent shifts in reward processing and emotional state","volume":"69","author":"Wheeler","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.brainresbull.2022.08.023_bib57","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/ntr\/ntab066","article-title":"Exenatide adjunct to nicotine patch facilitates smoking cessation and may reduce post-cessation weight gain: a pilot randomized controlled trial","volume":"23","author":"Yammine","year":"2021","journal-title":"Nicotine Tob. Res."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.08.023_bib58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41386-019-0531-4","article-title":"Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats","volume":"45","author":"Zhang","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2022.08.023_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108599","article-title":"A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats","volume":"192","author":"Zhang","year":"2021","journal-title":"Neuropharmacology"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923022002222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923022002222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:52:50Z","timestamp":1759783970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923022002222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":59,"alternative-id":["S0361923022002222"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2022.08.023","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, reduces cue- and drug-induced fentanyl seeking in rats","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2022.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}